It's 1969. 

A dermatologist named Albert Kligman is treating patients for acne at the University of Pennsylvania. 

His tool of choice is a vitamin A derivative (tretinoin), and it's working. 

But something else is happening too. Something he didn't plan for.

His patients are coming back with smoother skin. Fewer fine lines. Brighter skin.

Kligman hadn't set out to discover an anti-ageing compound. 

He was trying to clear breakouts only to realise the skin responded with something different. That accidental observation would later reshape an entire industry.

The Science We Didn’t Know

Vitamin A has been essential to human biology for as long as humans have existed. 

The first traces can be found in Egyptian texts like the Ebers Papyrus. 

The ancient Egyptians identified night blindness around 1500–2500 BC and treated it by using naturally occurring Vitamin A. 

By early 1913, scientists Elmer McCollum and Marguerite Davis identified it as a fat-soluble compound critical to cellular function. 

Night blindness, immune response, tissue repair — vitamin A was quietly running critical processes in the background.

But its connection to the skin took decades to surface.

Retinol is vitamin A in its purest over-the-counter (OTC) form. When applied topically, the skin converts it into retinoic acid — the biologically active compound that actually does the work. 

It binds to retinoic acid receptors in skin cells and instructs them to behave younger.

Specifically, it accelerates cellular turnover, the process by which old, damaged cells are shed and new ones emerge. 

It signals fibroblasts to produce more collagen.

It inhibits the enzymes that break down collagen. And it interrupts the pigmentation pathways that lead to uneven skin tone.

In short, it speaks the skin's own language.

How it landed from lab bench to prescription pad

Through the 1970s and '80s, tretinoin — the prescription-strength form of retinoic acid became a clinical staple.

Dermatologists were prescribing it for acne, photodamage, and the kind of skin ageing accelerated by decades of sun exposure.

The results were consistent, peer-reviewed, and replicable.

A landmark 1986 study published in the Journal of the American Academy of Dermatology by Kligman and colleagues formally documented tretinoin's ability to reverse visible signs of photoaging.

It wasn't anecdotal anymore. It was evidence.

But there was a problem.

Prescription tretinoin was potent and, for many patients, brutally so.

Redness, peeling, and sensitivity made early weeks of use feel more like damage than treatment. 

The barrier to entry was high. The dropout rate was higher.

Skincare needed a version of this molecule that more people could actually use.

The Turning Point

The problem with tretinoin was the fact that it worked. But for millions, it worked too aggressively.

Scientists and doctors knew that to make it scale, they needed something that was weaker than tretinoin, yet did the job. 

That's where retinol entered the picture.

Less potent than tretinoin, retinol requires an extra conversion step inside the skin before becoming active. 

That slower release meant significantly less irritation and, crucially, it meant cosmetic companies could formulate with it without a prescription requirement.

Through the late 1980s and into the 1990s, brands began incorporating retinol into serums and creams. The science held. 

The effects, while more gradual than tretinoin, were real and measurable. 

Consumer access to a clinically validated anti-ageing ingredient had just opened up entirely.

By the time the late '90s arrived, retinol wasn't a dermatologist's secret anymore. It was on the shelves. 

And once consumers started seeing results, it didn't need much explaining.

What Decades of Research Actually Tell Us

Today, retinol is one of the most studied topical ingredients in skincare history. The evidence base is deep. The science, consistent. 

Collagen stimulation is well-documented at concentrations as low as 0.1%. Cellular turnover benefits begin showing measurably within 12 weeks of regular use. Improvements in texture, pore appearance, and fine lines have been replicated across independent trials.

The molecule has also gotten smarter. 

Encapsulation technology now allows retinol to be delivered deeper into skin before activating, reducing surface irritation without compromising efficacy. 

Time-release formats extend activity overnight. 

The same fundamental science Kligman stumbled onto in the late '60s is now being formulated with precision.

The Larger Picture

Skincare trends come and go quickly. 

Ingredients rise on social media and fade just as fast.

Retinol has been here for over five decades. It survived the transition from prescription pad to pharmacy shelf. It outlasted countless competitors. 

It kept showing up in peer-reviewed research, decade after decade, doing exactly what the science said it would.

That's not marketing but a solid track record.

When Kligman's acne patients started coming back with unexpectedly better skin in 1969, they didn't know they were sitting at the beginning of something this revolutionary. 

And neither did he.

The only one who knew was the skin.